Skip to main navigation

Skip to content

Search

Toggle search form
- Search for:
Follow us on Twitter
Connect with us on LinkedIn

Investor Relations

Our Team
Our Development Program
For Patients
Investors/Media
Join Us
Contact Us

Search for:

Press Releases

Q3 2022 Infinity Pharmaceuticals, Inc. Earnings Conference Call

Nov 14, 2022 at 8:30 AM EST

Listen to webcast

Keyword Search

Year:

Summary Toggle Infinity Pharmaceuticals Announces Value Preservation and Maximization Plan

July 25, 2023 at 4:05 PM EDT
Summary Toggle Infinity Pharmaceuticals Announces Termination of Merger Agreement with MEI Pharma

July 24, 2023 at 8:30 AM EDT
Summary Toggle Infinity Pharmaceuticals Announces Stockholder Approval of Merger with MEI Pharma

July 14, 2023 at 1:00 PM EDT
Summary Toggle Infinity Pharmaceuticals Provides Additional Information on MARIO-8 Study Evaluating Eganelisib in Combination with the PD-1 Targeted Checkpoint Inhibitor Pembrolizumab (KEYTRUDA®) in Patients with Squamous Cell Cancer of the Head and Neck (SCCHN)

July 10, 2023 at 8:30 AM EDT
Summary Toggle ISS Recommends Infinity Pharmaceuticals Stockholders Vote FOR the Merger with MEI Pharma, Inc.

July 5, 2023 at 8:30 AM EDT
Summary Toggle MEI Pharma and Infinity Pharmaceuticals Host Video Webcast Providing Overview and Update on Pending Merger to Advance Three Promising Clinical Oncology Candidates

June 15, 2023 at 8:00 AM EDT
Summary Toggle Infinity Pharmaceuticals Announces Two Upcoming Presentations on PI3K-γ and Eganelisib by Dr. Judith Varner at the 2023 Annual Meeting of the American Association of Cancer Research

April 13, 2023 at 4:05 PM EDT
Summary Toggle Infinity Pharmaceuticals Reports Full Year 2022 Financial Results

March 28, 2023 at 4:05 PM EDT
Summary Toggle MEI Pharma and Infinity Pharmaceuticals Announce Definitive Merger Agreement to Advance Three Promising Clinical Oncology Candidates

February 23, 2023 at 7:00 AM EST
Summary Toggle Infinity Pharmaceuticals to Participate in Piper Sandler 34th Annual Healthcare Conference

November 22, 2022 at 8:35 AM EST

Pagination

Current page 1
Page 2
Page 3
Page 4
…
Next page
Last page

Shareholder Tools

RSS Feeds

RSS Feeds
Email Alerts

Email Alerts
Print

Print
Email

Email

Infinity Pharmaceuticals, Inc.

1100 Massachusetts Ave
Cambridge, MA 02138
617-453-1000

Terms and Conditions

Terms & Conditions
Privacy Policy
Forward Looking Statements

Connect With Us

Our Team

Our Team

Our Development Program

Our Development Program

Investor / Media

Investors/Media

Join Us

Join Us

© 2023 Infinity Pharmaceuticals, Inc. All Rights Reserved.